GlassScriptPhysician profile
John M Mcclure
NPI 1861435505
$1,240.45
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
See the full distribution for Adult Reconstructive Orthopaedic Surgery
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $665 · 2020: $230 · 2021: $309 · 2022: $36.87.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $404.14 | 2019-2022 | |
| Pacira Therapeutics, INC. | $315.30 | 2019-2021 | |
| Radius Health, INC. | $196.58 | 2019-2022 | |
| Innovation Technologies INC | $139.86 | 2020 | |
| Zimmer Biomet Holdings, INC. | $48.17 | 2019 | |
| Ferring Pharmaceuticals INC. | $37.54 | 2019-2021 | |
| Electronic Waveform Lab, INC. | $27.27 | 2021 | |
| Depuy Synthes Sales INC. | $24.39 | 2019 | |
| Vericel Corporation | $20.23 | 2021 | |
| Theragen, INC. | $15.85 | 2020 | |
| Horizon Therapeutics Plc | $11.12 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Mcclure listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.